Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Retagliptin phosphate for diabetic foot ulcer healing
ChiCTR2400087789Phase 4Not yet recruiting
- Sponsor
- Southwest Hospital of Army Medical University
- Start
- Aug 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of retagliptin in diabetic foot ulcer (DFU) (2 arms), sponsored by Southwest Hospital of Army Medical University. Primary endpoints: Ulcer complete healing rate and Drug side effects. Planned start Aug 2024; status: not yet recruiting.
02
Drugs
retagliptin
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on ChiCTR2400087789.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2400087789.